Editorial: Early detection, cancer interception, et al.: translating the multifaceted use of liquid biopsy to the management of early disease - Scorecard - MDSpire

Editorial: Early detection, cancer interception, et al.: translating the multifaceted use of liquid biopsy to the management of early disease

  • By

  • Letizia Pontolillo

  • Lorenzo Gerratana

  • Carolina Reduzzi

  • May 27, 2026

  • 0 min

Share

Clinical Scorecard: Advancing Early Detection and Cancer Interception Through Liquid Biopsy Applications in Early Disease Management

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              Editorial: Early detection, cancer interception, et al.: translating the multifaceted use of liquid biopsy to the management of early disease

              • by Letizia Pontolillo, Lorenzo Gerratana, Carolina Reduzzi

              • May 27, 2026

              Related Content

              Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

              PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

              Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study